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http://www.biomedcentral.com/1471-2180/13/41RESEARCH ARTICLE Open AccessHuman Streptococcus agalactiae strains in aquatic
mammals and fish
Christian MJ Delannoy1,2, Margaret Crumlish1, Michael C Fontaine2, Jolinda Pollock2,4, Geoff Foster3,
Mark P Dagleish2, James F Turnbull1 and Ruth N Zadoks2,5*Abstract
Background: In humans, Streptococcus agalactiae or group B streptococcus (GBS) is a frequent coloniser of the
rectovaginal tract, a major cause of neonatal infectious disease and an emerging cause of disease in non-pregnant
adults. In addition, Streptococcus agalactiae causes invasive disease in fish, compromising food security and posing
a zoonotic hazard. We studied the molecular epidemiology of S. agalactiae in fish and other aquatic species to
assess potential for pathogen transmission between aquatic species and humans.
Methods: Isolates from fish (n = 26), seals (n = 6), a dolphin and a frog were characterized by pulsed-field gel
electrophoresis, multilocus sequence typing and standardized 3-set genotyping, i.e. molecular serotyping and
profiling of surface protein genes and mobile genetic elements.
Results: Four subpopulations of S. agalactiae were identified among aquatic isolates. Sequence type (ST) 283
serotype III-4 and its novel single locus variant ST491 were detected in fish from Southeast Asia and shared a 3-set
genotype identical to that of an emerging ST283 clone associated with invasive disease of adult humans in Asia.
The human pathogenic strain ST7 serotype Ia was also detected in fish from Asia. ST23 serotype Ia, a subpopulation
that is normally associated with human carriage, was found in all grey seals, suggesting that human effluent may
contribute to microbial pollution of surface water and exposure of sea mammals to human pathogens. The final
subpopulation consisted of non-haemolytic ST260 and ST261 serotype Ib isolates, which belong to a fish-associated
clonal complex that has never been reported from humans.
Conclusions: The apparent association of the four subpopulations of S. agalactiae with specific groups of host
species suggests that some strains of aquatic S. agalactiae may present a zoonotic or anthroponotic hazard. Furthermore,
it provides a rational framework for exploration of pathogenesis and host-associated genome content of
S. agalactiae strains.
Keywords: Streptococcus agalactiae, Fish, Sea mammal, Aquatic epidemiology, Molecular epidemiology, MLST, PFGEBackground
Streptococcus agalactiae or group B streptococcus (GBS)
is the major cause of invasive neonatal infections in
industrialized countries [1,2]. Early and late onset disease
in infants of 1 to 6 or at least 7 days old, respectively, are
characterized by sepsis and meningitis. Early onset disease
usually results from mother-to-child transmission and can
be prevented through intrapartum chemoprophylaxis. The* Correspondence: ruth.zadoks@moredun.ac.uk
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reproduction in any medium, provided the orroutine use of screening protocols and intrapartum
chemoprophylaxis has led to decrease in the incidence of
early onset disease, whereas the incidence of late onset
disease is not affected [1,2]. Streptococcus agalactiae also
causes a considerable burden of disease in adults, with
case fatality rates approximating 15% in countries in
North America, Asia and Europe [2-4]. The incidence of
GBS disease in non-pregnant adults has increased in re-
cent years [3-5]. In adults, S. agalactiae may cause menin-
gitis or septicaemia as well as localized infections such as
subcutaneous abscesses, urinary tract infection or arthritis
[3]. The drivers behind emergence of S. agalactiae disease
in adults are poorly understood.ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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molecular methods have been used. This includes com-
parative typing methods, such as pulsed field gel elec-
trophoresis (PFGE), which is suitable for outbreak
investigations [6-8]. For population genetic analyses, highly
standardized and portable typing methods are preferable,
e.g. multilocus sequence typing (MLST), which targets the
core genome, or 3-set genotyping, which targets the
accessory genome content of S. agalactiae [9-11]. MLST is
an important tool for molecular epidemiology because the
MLST databases for individual pathogen species currently
cover far more isolates than have been characterized based
on whole genome sequencing [12]. Similarly, isolates that
have been characterized by 3-set genotyping still outnum-
ber isolates that have been characterized by whole genome
sequencing, thus providing a less detailed but broader
frame of reference than offered by whole genome
sequences. MLST is an unambiguous method based on
sequencing of the internal portion of selected housekeep-
ing genes [13]. It is used to define sequence types (STs),
which may be associated with specific disease syndromes.
For example, ST17 is more prevalent among isolates from
invasive disease in infants than among carriage isolates
from pregnant adults [1,13]. Three-set genotyping en-
compasses molecular serotyping (MS) and profiling of sur-
face protein genes and mobile genetic elements (MGE),
and allows for further differentiation of isolates belonging
to the same ST [11]. For example, ST283 isolates with mo-
lecular serotype III-4, C-α protein and C-α protein
repeating units and the MGEs IS1381, ISSag1, and ISSag2
are associated with the emergence of GBS meningitis in
adults in Southeast Asia [7,8].
Invasive disease due to S. agalactiae is not limited to
humans. Other species affected include terrestrial
mammals such as cattle, dogs and cats [14,15] and aquatic
or semi-aquatic species such as sea mammals [16,17],
crocodiles [6], bullfrogs [18] and fish [16,19]. Outbreaks of
streptococcosis due to S. agalactiae have been described
in wild fish, e.g. in mullet in Kuwait bay [16,20] and in
giant Queensland Grouper and other wild fish in Australia
[21]. S. agalactiae is also a major pathogen in farmed fish,
particularly in tilapia [22-24]. Consumption of fish has
been associated with an increased risk of S. agalactiae
serotype Ia and Ib colonization in people [25]. Further-
more, MLST, molecular serotyping and challenge studies
have shown that invasive disease in humans and fish may
be caused by the same strains of S. agalactiae [16,19]. The
aim of the current paper is to enhance our knowledge
of the molecular epidemiology of S. agalactiae in fish
and other aquatic species, with emphasis on use of
standardized typing systems that cover housekeeping
genes as well as virulence genes and that allow for assess-
ment of transmission potential between aquatic species
and humans based on comparison with existing databases.Methods
Isolate collection and identification
A collection of 34 S. agalactiae isolates recovered from
aquatic hosts was assembled, including isolates from
poikilothermic and homeothermic host species originat-
ing from multiple countries and continents (Figure 1).
Of 34 isolates, 13 represented 3 separate disease
outbreaks (5 isolates from an outbreak Kuwait, 4 from
Honduras and 4 from Colombia) with the remaining 21
isolates each representing a single, unrelated outbreak or
death. Thus, isolates in this study represented 24
epidemiologically independent events. Most fish isolates
(n=18) originated from infections in farmed tilapia
(Oreochromis sp.) from Honduras, Colombia, Costa Rica,
Belgium, Thailand and Vietnam. The remaining fish
isolates originated from infections in wild Klunzinger’s
mullets (n=5; Liza klunzinger) that were part of an out-
break of streptococcosis in Kuwait or from ornamental
fish from Australia, namely a rosy barb (Puntius
conchonius), a golden ram (Mikrogeophagus ramirezi)
and an undetermined fish species. Sea mammal isolates
(n=7) were recovered at post-mortem from lung swabs
of 1 bottlenose dolphin (Tursiops truncatus) and 6 grey
seals (Halichoerus grypus) that had stranded at various
sites around the coast of Scotland. Finally, one amphib-
ian isolate originating from an infected farmed bullfrog
(Rana rugurosa) in Thailand was available for molecular
characterisation.
Bacterial isolates were streaked onto 5% sheep blood
agar plates (E&O Laboratories, Bonnybridge, United
Kingdom) and grown aerobically at 27 to 28C for
48h in order to assess purity and haemolysis properties.
This temperature is commonly used for culture of
S. agalactiae from fish [26]. Isolates were checked for
Gram reaction and morphology and tested in a group B-
specific latex agglutination test (Slidex Strepto Plus B;
bioMérieux, Marcy L'Étoile, France). Single colonies
were transferred to Brain Heart Infusion (BHI) broth
(Oxoid, Basingstoke, United Kingdom) and incubated
with gentle shaking at 28C for 12h (ß-haemolytic
strains, fast growing) or 48h (non-haemolytic strains,
slow growing). Species identity of S. agalactiae was
confirmed by polymerase chain reaction (PCR), using
forward primer STRA-AgI (50-AAGGAAACCTGCCAT
TTG-03) and reverse primer STRA-AgII (50-TTAACC
TAGTTTCTTTAAAACTAGAA-30), which target the
16S to 23S rRNA intergenic spacer region [27]. Broth
cultures were also used for PFGE as described below.
Comparative typing: PFGE
Bacterial cells were pelleted by centrifugation of 1 ml of
incubated BHI, re-suspended in 0.5 ml of TE buffer (10
mM Tris-HCl, 1mM EDTA), warmed to 56C and mixed
with 0.5 ml of 2% (weight/vol) low-melting point agarose
Figure 1 Overview of Streptococcus agalactiae origin, isolate number (n) and results of phenotypic and genotypic characterization.
Results include analysis of haemolysis (Haem), multilocus sequence typing (MLST), pulsed-field gel electrophoresis (PFGE), molecular serotyping
(MS), and profiling of surface protein genes and mobile genetic elements. Trees for MLST and PFGE results were constructed using unweighted
pair group method analysis (UPGMA). Boxes enclose major clonal complexes (CCs) or sequence types (STs). STs shown in bold were first
identified in the current study. ND: not determined.
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buffer. The mixture was then pipetted into reusable plug
moulds (Catalogue number 170-3622; BioRad Laborator-
ies, Hemel Hempstead, United Kingdom) producing
20 × 9 × 1.2 mm3 agarose blocks. Each solidified plug
was placed into 2 ml of TE buffer containing 4 mg of lyso-
zyme (Sigma Aldrich, Poole, United Kingdom) (2 mg ml-1)
and incubated overnight at 37C with gentle shaking. The
buffer was then replaced with 2 ml of ES buffer (0.5 M
EDTA–1% (weight/vol) N-lauroyl sarcosine [pH 8.0 to
9.3]) supplemented with 4 mg of proteinase K (Promega,
Southampton, United Kingdom) (2 mg ml-1) and in-
cubated at 56C for a minimum of 48 hr. Plugs were
washed 6 times for 1 hr in TE buffer at room temperature
and with gentle shaking. A slice (4 × 4 × 1.2 mm3) from
each plug was exposed to digestion with restriction endo-
nuclease SmaI (20 U in 100 μl of fresh reaction buffer;
New England Biolabs, Hitchin, United Kingdom) at 25C
overnight. PFGE was performed with a CHEF-mapper
system (BioRad Laboratories) in 0.5 × TBE using a 1%(weight/vol) agarose gel (Pulsed Field Certified Agarose,
BioRad Laboratories), a run time of 24 hr and switch
time of 3-55 s (linear ramp) at 14C. Patterns were
observed by UV transillumination after SYBR Gold
staining (Invitrogen, Paisley, United Kingdom). Computer-
assisted data analysis and dendogram construction were
performed with Phoretix 1D Pro software (TotalLab Ltd,
Newcastle upon Tyne, United Kingdom). Similarities be-
tween PFGE patterns were also assessed visually using
standard criteria [10].
Housekeeping genes: multilocus sequence typing
MLST consisted of the amplification by PCR and se-
quencing of seven housekeeping genes, namely adhP,
atr, glcK, glnA, pheS, sdhA, and tkt [13]. Consensus
sequences were trimmed in SeqMan (DNAStar, London,
United Kingdom), and the S. agalactiae database [28]
was used for allele and sequence type (ST) assignments.
Sequences of novel alleles were submitted to the data-
base curator for allocation of new allele numbers and
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unweighted pair group method in PHYILIP and
Phylodendron was used to visualize the relationship be-
tween allelic profiles obtained from the isolates. The
complete allelic profile list from the S. agalactiae MLST
database was downloaded (last accessed 7 November
2012) [28] and eBURST groups were identified based on
sharing of 6 out of 7 alleles using standard eBURST
methodology [29]. In addition, a population snapshot of
the entire S. agalactiae population was created in
eBURST to show the position of STs from our study in
relation to all known STs, which predominantly originate
from isolates of human origin. Finally, for STs that were
identified in the current study and that did not form
part of an eBURST group, the existence of double locus
variants (DLVs) and triple locus variants (TLVs) was
explored via ST query in the S. agalactiae MLST data-
base [28].
Virulence genes: three-set genotyping
A 3-set genotyping system, comprising MS, surface pro-
tein gene profiles and MGE profiles, was used. Molecular
serotyping was performed using multiplex-PCR assays
[16]. Non-typeable (NT) isolates were further investigated
using other primer sets [30] and serosubtyping of MS III
isolates was performed [31]. Presence of surface protein
genes was determined by PCR and sequencing of PCR
products, using primers targeting the bca, bac, alp1, alp2,
alp3 and alp4 genes [32]. Finally, the prevalence of 7
MGE, corresponding to 1 group II intron (GBSi1) and 6
insertion sequences (IS1381, IS861, IS1548, ISSa4, ISSag1
and ISSag2) was evaluated by PCR and amplicon identity
was confirmed by sequencing of PCR products [23,33].
Results
Isolate collection and identification
All isolates were Lancefield Group B, Gram-positive
cocci appearing in pairs and chains. They were either β-
haemolytic or non-haemolytic on sheep blood agar
(Figure 1). All were confirmed as S. agalactiae by
species-specific PCR.
PFGE analysis
All isolates were typeable by SmaI macrorestriction and
13 pulsotypes were identified. Pulsotypes were indistin-
guishable when multiple isolates from a single outbreak
were analysed. In some cases, pulsotypes were also indis-
tinguishable for isolates from different host species or
countries, e.g. for bullfrog and tilapia isolates from Thai-
land or for tilapia isolates from Honduras, Colombia and
Costa Rica (Figure 1). Despite efforts to identify poten-
tial epidemiological relationships between farms sharing
the same pulsotype, e.g. through shared broodstock or
feed companies, no such links could be identified andeach outbreak is considered to be epidemiologically
independent.
MLST and eBURST analysis
Among the 34 S. agalactiae isolates, 8 STs were
observed, including 2 new STs, i.e. ST491 and ST500
(Figure 1). The new STs were SLVs of known STs and
resulted from single nucleotide changes. STs were identi-
cal when multiple isolates from a single outbreak were
analysed. In several cases, STs were also identical between
isolates from epidemiologically unrelated animal deaths,
outbreaks, countries or host species. For example, ST261
was associated with three epidemiologically unrelated fish
death in Australia; ST260 was found in tilapia from
Honduras, Colombia and Costa Rica; and ST7 was found
in a bullfrog and tilapia from Thailand and in mullet from
Kuwait (Figure 1). The ST7 isolates from Thailand
originated from 5 provinces (Nakhon Sawan Province –
frog farm; Kanchanaburi Province – tilapia farm; Nakhon
Pathom Province - 2 tilapia farms; and Saraburi Province –
tilapia farm) and were epidemiologically unrelated. The
two ST500 isolates from Thailand originated from tilapia
farms in Mukdahan Province and Phetchaburi Province,
respectively.
E-burst analysis (Figure 2) showed that all piscine
isolates from Asia and the Middle-East and the frog
isolate from Asia (ST7 and its SLV ST500; ST283 and
its SLV ST491) belonged to 2 related subgroups, both
of which are part of eBURST group 1. The bottlenose
dolphin isolate from the UK (ST399) also belonged to
eBURST group 1. This large eBURST group includes a
number of major subgroups that used to be separate
eBURST groups or clonal complexes (CCs). For ease
of reference and comparison with the literature, such
subgroups or subCCs are indicated in the figure and
subsequent text by their founding ST. All grey seal
isolates from the UK belonged to ST23, which is the
founder of eBURST group 2 or CC23 and not related to
ST7 or ST283. Piscine isolates from Latin America
(ST260) were part of a small eBURST group that also
includes ST257, ST259, ST552 and ST553 (Figure 2).
The most likely founder of this eBURST group is ST552
and the group is also referred to as CC552. Based on
additional analysis of DLVs, ST261 and ST246 may also
be related to CC552 whilst ST258 is a TLV of CC552
(Figure 3).
Three-set genotyping
Using the method of Evans and colleagues [16], isolates
were identified as serotype Ia, Ib or NT. Further investi-
gation of NT isolates with additional primer sets [30,31]
showed that the isolates belonged to serotype III
subserotype 4. Based on the combination of serotype,
surface protein genes and MGE, seven 3-set genotypes
Figure 2 Population snapshot of S. agalactiae constructed in eBURST. In addition to the 9 eBURST groups that are shown, 36 singletons
were present in the database (last accessed 7 November 2012). Founders of major clonal complexes (ST1, ST17, ST19, all of which form part of
eBURST group 1, and ST23, which is the founder of eBURST group 2) and sequence types (ST) identified in the current study are labelled. Italics
indicate STs isolated from fish, bold italics indicate the ST from fish and a frog, and shaded labels indicate STs from sea mammals. All
β-haemolytic S. agalactiae isolates from fish belonged to a single branch of eBURST group 1, all seal isolates (n=6) belonged to eBURST group 2
and all non-haemolytic isolates belonged to two small eBURST groups that included ST260 and ST261.
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identical when multiple isolates from a single outbreak
were analysed. Piscine and amphibian isolates from Asia
and the Middle-East and all mammalian isolates were
positive for IS1381 and ISSag2. IS861 was always found
in combination with GBSiI and vice versa but rarely in
combination with ISSag1. ISSag1 was found in all mam-
malian isolates tested but only 3 of 21 epidemiologically
independent non-mammalian isolates carried ISSag1.eBURST group 9
eBURST group 4
ST257 ST552 ST260 ST259 ST258
ST553
ST261ST246
Figure 3 Overview of sequence types (ST) of Streptococcus
agalactiae that have only been isolated from poikilothermic
host species (fish, frog). STs that share 6 of 7 alleles, i.e. single
locus variants, are connected by full lines and grouped into eBURST
groups. STs that are members of different eBURST groups but share
5 of 7 alleles, i.e. dual locus variants, are connected by dashed lines.
ST258 shares 4 of 7 alleles with ST259 and the relationship of this
triple locus variant to the eBURST groups is represented by a dotted
line. All STs in this diagram share fewer than 4 alleles with all STs
that have been identified in homeothermic host species
(e.g. humans and seals).When the Cβ protein gene (bac) was present, it was
always found in association with the Cα protein gene
(bca) but bca could also present in the absence of bac
(Figure 1). Piscine isolates from Latin America (n=6),
Australia (n=3) and Europe (n=1), all shared serotype
Ib (Figure 1) but none of the surface protein genes or
MGE investigated in this study were detected in any of
these isolates.
Comparison across methods
All β-haemolytic isolates (n=21, representing 17
epidemiologically independent events) belonged to CCs
that are also found in humans and carried at least 3
MGEs (Figure 1). Each CC correlated with a PFGE clus-
ter, although MLST could be more discriminatory than
PFGE and vice versa. For example, multiple PFGE types
were identified in ST7 and in ST23 (Figure 1). Con-
versely, multiple STs were identified within PFGE types
in CC7 (ST7 and ST500) and CC283 (ST283 and ST491).
Results from 3-set genotyping were concordant with
MLST and PFGE typing and origin of isolates. All isolates
from CC7 (n=14, representing 9 epidemiologically inde-
pendent events) carried at least 2 surface protein genes
and 4 MGEs (IS1381, IS861, ISSag2 and GBSi1), which is
more than was observed in any other CC in this study.
Within CC7, the dolphin isolate was the most divergent
isolate based on MLST, PFGE typing, serotyping and
number of surface protein genes. The dolphin isolate and
the outbreak strain from Kuwait had one extra MGE,
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which were identical to each other in 3-set genotype.
Isolates in CC283 (n=2) and CC23 (n=6) carried the same
MGEs (IS1381, IsSag1 and IsSag2) but differed from each
other in presence of surface protein genes. Within CC23,
two closely related PFGE clusters were observed that
corresponded with presence or absence of the surface
protein gene alp1. All non-haemolytic isolates (n=13,
representing 7 epidemiologically independent events)
belonged to STs that have not been identified in humans
and none of these isolates carried any of the surface pro-
tein genes or MGEs that were examined (Figure 1).
Discussion
Streptococcus agalactiae from sea mammals, fish and a
frog belonged to 4 subpopulations based on a combin-
ation of two standardized typing methods which target
the core genome and the accessory genome, respectively.
Of the 4 subpopulations that were identified, 3 have also
been found in humans, both as carriage strains and as
the cause of invasive disease in neonates or adults, whilst
to date the fourth one has only been reported from poi-
kilothermic animals.
S. agalactiae CC283 is associated with invasive disease in
humans and fish
ST283 with molecular serotype III-4 has been associated
with invasive disease in non-pregnant adults in Hong
Kong [7] and was isolated from fish in Thailand in our
study. Isolates from humans and fish also shared the
presence of the C-alpha encoding gene as well as identi-
cal MGE profiles. The same 3-set genotype was found in
an SLV of ST283, the novel ST491, which was isolated
from fish in Vietnam in our study. ST283 and another
one of its SLVs, ST11, have previously been linked to an
increase in group B streptococcal meningitis in adults in
Southeast Asia [7]. In France, ST283 serotype III has
been isolated from cases of osteoarticular disease in
non-pregnant adults [34]. The 3-set genotype shared by
human isolates from Hong Kong and tilapia isolates
from Southeast Asia in our study had already been
reported from tilapia in Thailand, but MLST data were
not published for those isolates [23]. The recent emer-
gence or recognition of invasive ST283 and its SLVs in
humans and fish in Southeast Asia suggests that there
may be an epidemiological connection between the two
host species, as previously described for a closely related
streptococcal species, Streptococcus iniae [35]. Such a
connection could result from human-to-animal trans-
mission, animal-to-human transmission or joint ex-
posure to a shared source. Further study of ST283 and
the epidemiological connection between humans and
fish will be needed to elucidate potential transmission
mechanisms and risks.S. agalactiae CC7 is associated with carriage and disease
in humans, a bullfrog, fish and dolphins
In humans, ST7 causes invasive disease in neonates and
adults [13,16] and the pathogenicity of human ST7
isolates to fish is well-established [19]. ST7 may also
occur as vaginal carriage isolates in humans [13,36]. ST7
was held responsible for a major fish kill in Kuwait bay
[16] and results from our study using isolates from dif-
ferent fish from the same outbreak confirm this. Human
sewage was considered a likely source of this outbreak
[20], a route of transmission that is consistent with com-
mensal occurrence of strains in the human urogenital
tract. We report here for the first time the detection of
ST7 in an amphibian. Previous reports on the occur-
rence of S. agalactiae in frogs mention non-haemolytic
GBS strains [18,37] but all ST7 isolates in our study
and in previous studies of aquatic S. agalactiae were β-
haemolytic. Thus, it is unlikely that infections described
previously in frogs were due to ST7. Like most ST7
isolates in our study, the frog isolate originated from
Thailand, where this ST is common in farmed tilapia
(Figure 1).
S. agalactiae has been isolated from captive and wild
dolphins [17,38]. ST7 was cultured from a bottlenose
dolphin (Tursiops truncates) that died during the Kuwait
Bay fish kill but no definitive link between bacterial iso-
lation and death could be established [38]. Similarly, we
describe the first case of ST399 in a free-ranging bottle-
nose dolphin calf from Scotland without definitive evi-
dence of a causal association with the animal’s death,
which was attributed to trauma and infanticide. ST399 is
a rare SLV of ST12 and does not appear to be closely
related to ST7 in eBURST analysis of the current MLST
database (Figure 2). However, ST399 is a DLV of ST7
and alternative methods, e.g. clustering of MLST data
using the unweighted pair group method, suggest that
ST399 should be classified as a member of CC7 [39].
Due to the low number of dolphin isolates available, it is
not possible to determine whether the isolation of two
CC7 strains from temporally and geographically unre-
lated dolphins is coincidental or reflective of a host pre-
dilection. Like ST7, ST399 may occur as a vaginal
coloniser in healthy women [39]. Thus, its presence in
sea water could result from microbial contamination by
human effluent.
S. agalactiae ST23 is associated with humans and seals
but not with fish
Streptococcus agalactiae has been detected in grey seals
(Hallichoerus grypus) and in Antarctic fur seals
(Arctocephalus gazelles) but those descriptions predate
the development of MLST [40,41]. S. agalactiae was
identified in 9 grey seals under the Scottish Strandings
Scheme whereas examination of a larger number of
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failed to recover S. agalactiae, suggesting that among
Scottish pinnipeds, S. agalactiae has a preference for
grey seals. Complete molecular typing data was available
for 6 isolates, which are included in the current study,
whilst MLST data was available for the remaining 3
isolates. One of the grey seals had died of a systemic in-
fectious process, whilst other animals with S. agalactiae
died with signs of storm damage, hypothermia, starva-
tion, trauma or lung emphysema, in agreement with pre-
vious studies [40,41]. All seal isolates (n = 9) belonged to
ST23. Within ST23, molecular serotypes Ia and III pre-
dominate [1,14]. ST23 serotype Ia is linked to humans
whereas ST23 serotype III is primarily found in dairy
cattle where it is a causative agent of mastitis, inflamma-
tion of the mammary gland [14,15]. All seal isolates
included in the current study (n = 6) had serotype Ia,
suggesting a human origin. In humans, ST23 is common
as vaginal-rectal carrier strain in adults although it may
also cause neonatal invasive disease [1,13]. Given the
predominant niche of ST23 in humans, it is conceivable
that its presence in seals is due to microbial contamin-
ation of surface water. ST23 probably has the broadest
known host range of all S. agalactiae STs. Both homeo-
thermic and poikilothermic species can be affected, includ-
ing humans, cattle, dogs, crocodiles and seals [6,14,15].
Despite the high prevalence of ST23 in humans, its wide
host range and its ability to affect aquatic mammals and
semi-aquatic reptiles, there are no reports on occurrence
of ST23 in fish. This may reflect the relatively small num-
ber of fish isolates characterized to date or it may indicate
true biological differences, e.g. an inability to infect fish.
Challenge studies using ST23 are required to assess its
ability to cause disease in fish. If ST-associated differences
in virulence are confirmed, comparative genomic analysis
of human, fish, seal and bovine isolates may help to iden-
tify molecular correlates of virulence.
S. agalactiae ST260 and ST261 are associated with fish
but not with humans
The final subpopulation in our collection consisted of
non-haemolytic strains of S. agalactiae. Non-haemolytic
S. agalactiae may cause invasive disease such as endo-
carditis in adult humans [42] but no MLST data on
non-haemolytic human isolates could be found. The
prevalence of non-haemolytic S. agalactiae among car-
riage isolates has been estimated at 5 to 8%, although
this value may be underestimated in studies that use β-
haemolyis as a diagnostic criterion for identification of
the organism [43]. All non-haemolytic isolates in our
collection belonged to serotype Ib, a serotype that has
been associated with β-haemolytic and non-haemolytic
human isolates [1,37]. The subpopulation of non-
haemolytic serotype Ib isolates in our study encompassedall fish isolates that did not originate from Southeast Asia,
suggesting an association between geographic origin and
strain. The association with host species and geographic
origin is not absolute, as β-haemolytic serotype Ib isolates
and ST261 have also been reported from frogs [37,44] and
ST261 has been reported in fish from Indonesia [45]. This
is the first report of ST261 in aquarium fish, which
originated from Australia. Outbreaks of streptococcosis in
wild fish have occurred repeatedly in Australia in the past
few years [21]. The isolates causing disease in Queensland
grouper and other reef fish were non-haemolytic with
serotype Ib, suggesting that they belong to the fish-
associated subpopulation of S. agalactiae. Human strains,
such as ST7 or ST23, could come into contact with reef
fish through surface water contamination by effluent
or divers but would be expected to be haemolytic. It is
unknown whether there is an epidemiological connec-
tion between disease in aquarium fish and reef fish, e.g.
due to capture of reef fish or release of aquarium fish into
the wild.
Using standard eBURST group definitions, ST260 but
not ST261 is recognized as part of CC552 (Figure 2).
However, ST261 is a DLV of multiple CC552 members
and could be considered a member of the same group
(Figure 3). This group also includes ST246, which has
been isolated from trout, and ST257 and 259, which
have been isolated from tilapia [14,16]. ST258, which
has been isolated from striped bass [16], is loosely
connected to this group, which does not include any
isolates from homeothermic host species. Using the 3-
set genotyping system, no surface protein genes or
MGEs were detected among isolates from this group,
further supporting that it is not closely related to any of
the known clonal complexes of S. agalactiae found in
humans. ST261 was recently discovered in doctor fish
(Gara rufa) that are used in foot spas to remove dead
skin from people’s feet and concern has been expressed
that repeated exposure of fish-adapted strains to such an
environment could eventually lead to human infections
[45]. In the laboratory, members of the group that
includes ST260 and ST261 do not grow well at 37C,
which may explain their current absence from homeo-
thermic species. A vaccine to protect fish from non-
haemolytic S. agalactiae is commercially available, but
this vaccine does not provide protection to haemolytic
strains [14]. Thus, vaccination of fish can be used to
limit production losses in some situations, but it does
not protect against the most commons strains in
Southeast Asia or against zoonotic infections from fish
or fish products.
Conclusions
Based on standardized molecular typing of housekeeping
genes and virulence genes, S. agalactiae strains that have
Delannoy et al. BMC Microbiology 2013, 13:41 Page 8 of 9
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and adult invasive disease in humans can also be found
in fish, frogs and sea mammals. In particular, strains
belonging to ST23, which is a common carriage strain in
humans, were associated with seals, where they may be
indicators of environmental pollution rather than causa-
tive agents of disease. ST23 was not identified in any
fish. Strains belonging to ST7 were associated with a
bullfrog and fish from South-East Asia whilst strains
belonging to ST283 and showing the same virulence
gene profile as human invasive isolates were isolated
from fish in Asia. This suggests that there may be
exposure of humans and fish to similar environmen-
tal sources of ST7 and ST283, or transmission of
S. agalactiae between the different host species. Finally,
strains belonging to ST260 and ST261 were associated
with fish from the Americas, Europe and Australia.
These strains, and other members of their clonal com-
plex, have only been reported from poikilotherms. Com-
parative genomic analysis and functional studies of
strains that do not appear to affect fish, e.g. ST23, and
strains that primarily affect fish, e.g. ST260 and ST261,
may provide insight into host-adaptation of S. agalactiae.
Epidemiological studies are needed to provide insight into
the likelihood and routes of interspecies transmission of
strains that are associated with fish, sea mammals and
invasive disease in humans as well as control measures
needed to prevent transmission and disease.
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